InvenireX
Newcastle-based BioTech company that aims to disrupt the market for PCR laboratory tests
InvenireX has raised €2.9M across 2 funding rounds from 5 investors, most recently a Seed round in Nov 2025. Based in Newcastle upon Tyne, UK; active in Healthtech. Data as of 28 Oct 2026.
Newcastle upon Tyne, UKinvenirex.co.uk ↗
Total raised
€2.9M
€2,852,489
Funding rounds
2
Investors
5
distinct backers
Active since
2024-03
latest 2025-11
Funding by year
EUR raised per yearInvenireX — funding by year — interactive chart.
Data table
| InvenireX — funding by year | |
|---|---|
| 2024 | €585k |
| 2025 | €2.3M |
Signals
High confidenceRaise-next likelihood66
base rate 44% for Seed
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood12
base rate 11% (2+ rounds)
- ▼ Young (<3y)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-11-18 | Seed | €2.3M | Angel Investors,Cambridge Technology Capital,DSW Ventures,Innovate UK,XTX Ventures | View deal → |
| 2024-03-19 | Other | €585k | DSW Ventures,XTX Ventures | View deal → |